LIVERPOOL SCHOOL OF TROPICAL MEDICINE
- Country
- 🇬🇧United Kingdom
- Ownership
- -
- Established
- 1898-01-01
- Employees
- 650
- Market Cap
- -
- Website
- https://www.lstmed.ac.uk/
Clinical Trials
47
Trial Phases
5 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (36 trials with phase data)• Click on a phase to view related trials
Safety of Antimalarials in the FIRst trimEster
- Conditions
- Malaria, PregnancyMalaria, AntepartumMalaria (Uncomplicated)
- Interventions
- Drug: Pyronaridine-artesunate (PA)Drug: dihydroartemisinin-piperaquine (DP)
- First Posted Date
- 2025-05-08
- Last Posted Date
- 2025-05-08
- Lead Sponsor
- Liverpool School of Tropical Medicine
- Target Recruit Count
- 1510
- Registration Number
- NCT06962319
- Locations
- 🇧🇫
Clinical Research Unit of Nanoro (CRUN), Institut de Recherche en Sciences de la Santé, Direction Régionale de l'Ouest (IRSS-DRO), Nanoro, Burkina Faso
🇰🇪KEMRI Centre for Global Health Research (CGHR), Kisumu, Kenya
🇲🇱Malaria Research and Training Center, University of Sciences, Techniques, and Technologies of Bamako (USTTB),, Bamako, Mali
Characterising the Loss of Haemostasis in Haemorrhagic Fever With Renal Syndrome
- Conditions
- Haemorrhagic Fever With Renal Syndrome
- First Posted Date
- 2025-04-25
- Last Posted Date
- 2025-04-25
- Lead Sponsor
- Liverpool School of Tropical Medicine
- Target Recruit Count
- 62
- Registration Number
- NCT06944275
Development of a Rapid Diagnostic Test to Identify Crimean-Congo Hemorrhagic Fever - Research and Development Testing
- Conditions
- Infectious Diseases, Emerging
- First Posted Date
- 2025-03-25
- Last Posted Date
- 2025-03-25
- Lead Sponsor
- Liverpool School of Tropical Medicine
- Target Recruit Count
- 200
- Registration Number
- NCT06894758
- Locations
- 🇹🇷
Ondokuz Mayis University (OMU) Faculty of Medicine, Department of Clinical Microbiology and Infectious Diseases, Samsun, Samsun, Turkey
🇹🇷Department of Infectious Diseases and Clinical Microbiology, Medical Faculty, Sivas Cumhuriyet University, Sivas, Sivas, Turkey
UMIT-2 - Adaptive Phase IIb Platform Trial to Determine the Efficacy and Safety of Therapeutics for CCHF
- Conditions
- Crimean-Congo Hemorrhagic Fever
- Interventions
- First Posted Date
- 2025-03-06
- Last Posted Date
- 2025-03-06
- Lead Sponsor
- Liverpool School of Tropical Medicine
- Target Recruit Count
- 378
- Registration Number
- NCT06860334
Mapping Snakebite Risk in Ghana and Rwanda
- Conditions
- SnakebiteSnake Envenomation
- First Posted Date
- 2025-02-05
- Last Posted Date
- 2025-02-05
- Lead Sponsor
- Liverpool School of Tropical Medicine
- Target Recruit Count
- 32000
- Registration Number
- NCT06808789
- Prev
- 1
- 2
- 3
- 4
- 5
- 9
- Next
News
Breakthrough Universal Antivenom Developed Using Blood of Man Bitten 200+ Times
Scientists have developed a groundbreaking antivenom using antibodies from Tim Friede, who voluntarily endured over 200 snake bites and 700 venom injections over nearly 20 years.
£10M Investment in AI-Powered Robotic Labs to Accelerate Infectious Disease Treatment Development
Liverpool School of Tropical Medicine receives £10M funding to establish AI-powered robotic Containment Level 3 laboratories for accelerating development of treatments for high-risk infectious diseases.
Nitisinone Shows Promise as Novel Malaria Control Strategy by Making Human Blood Lethal to Mosquitoes
Researchers have discovered that nitisinone, a drug used to treat rare genetic disorders, makes human blood toxic to mosquitoes that transmit malaria, offering a potential new control strategy.